Fig. 2
From: Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner
Tretinoin does not increase the sensitivity of AB1-HA to cyclophosphamide or its metabolites in vitro. (A) Viability of AB1-HA cells treated with increasing concentrations of tretinoin. (B-D). Viability of AB1-HA treated with increasing concentrations of acrolein (B), mafosfamide (C) or cyclophosphamide (D) with or without 50 µM of tretinoin. Viability was determined by the MTT assay. Data points are the mean ± SD of three independent experiments